Veronese ML - Search Results

1

Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.

Veronese ML, Stevenson JP, Sun W, Redlinger M, Algazy K, Giantonio B, Hahn S, Vaughn D, Thorn C, Whitehead AS, Haller DG, O'Dwyer PJ. Veronese ML, et al. Eur J Cancer. 2004 Mar;40(4):508-14. doi: 10.1016/j.ejca.2003.10.022. Eur J Cancer. 2004. PMID: 14962716 Clinical Trial.

2

Monoclonal antibodies in the treatment of colorectal cancer.

Veronese ML, O'Dwyer PJ. Veronese ML, et al. Eur J Cancer. 2004 Jun;40(9):1292-301. doi: 10.1016/j.ejca.2004.02.014. Eur J Cancer. 2004. PMID: 15177487 Review.

3

Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors.

Veronese ML, Flaherty K, Kramer A, Konkle BA, Morgan M, Stevenson JP, O'Dwyer PJ. Veronese ML, et al. Cancer Chemother Pharmacol. 2005 May;55(5):497-501. doi: 10.1007/s00280-004-0938-3. Epub 2005 Feb 12. Cancer Chemother Pharmacol. 2005. PMID: 15711828 Clinical Trial.

4

A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer.

Veronese ML, Sun W, Giantonio B, Berlin J, Shults J, Davis L, Haller DG, O'Dwyer PJ. Veronese ML, et al. Br J Cancer. 2005 May 23;92(10):1846-9. doi: 10.1038/sj.bjc.6602569. Br J Cancer. 2005. PMID: 15870719 Free PMC article. Clinical Trial.

5

Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.

Veronese ML, Algazy K, Bearn L, Eaby B, Alavi J, Evans T, Stevenson JP, Shults J. Veronese ML, et al. Cancer Invest. 2005;23(4):296-302. doi: 10.1081/cnv-61528. Cancer Invest. 2005. PMID: 16100941 Clinical Trial.

6

Mechanisms of hypertension associated with BAY 43-9006.

Veronese ML, Mosenkis A, Flaherty KT, Gallagher M, Stevenson JP, Townsend RR, O'Dwyer PJ. Veronese ML, et al. J Clin Oncol. 2006 Mar 20;24(9):1363-9. doi: 10.1200/JCO.2005.02.0503. Epub 2006 Jan 30. J Clin Oncol. 2006. PMID: 16446323 Clinical Trial.

7

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.

Demetri GD, Casali PG, Blay JY, von Mehren M, Morgan JA, Bertulli R, Ray-Coquard I, Cassier P, Davey M, Borghaei H, Pink D, Debiec-Rychter M, Cheung W, Bailey SM, Veronese ML, Reichardt A, Fumagalli E, Reichardt P. Demetri GD, et al. Among authors: veronese ml. Clin Cancer Res. 2009 Sep 15;15(18):5910-6. doi: 10.1158/1078-0432.CCR-09-0542. Epub 2009 Sep 1. Clin Cancer Res. 2009. PMID: 19723647 Free PMC article. Clinical Trial.

8

Aberrant FHIT transcripts in Merkel cell carcinoma.

Sozzi G, Alder H, Tornielli S, Corletto V, Baffa R, Veronese ML, Negrini M, Pilotti S, Pierotti MA, Huebner K, Croce CM. Sozzi G, et al. Among authors: veronese ml. Cancer Res. 1996 Jun 1;56(11):2472-4. Cancer Res. 1996. PMID: 8653678

9

Structure and expression of the human FHIT gene in normal and tumor cells.

Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K. Druck T, et al. Among authors: veronese ml. Cancer Res. 1997 Feb 1;57(3):504-12. Cancer Res. 1997. PMID: 9012482

10

The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene.

Veronese ML, Bullrich F, Negrini M, Croce CM. Veronese ML, et al. Cancer Res. 1996 Feb 15;56(4):728-32. Cancer Res. 1996. PMID: 8631004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters